Bio-Medical Applications Of Texas in Bastrop, Texas - Dialysis Center

Bio-Medical Applications Of Texas is a medicare approved dialysis facility center in Bastrop, Texas and it has 13 dialysis stations. It is located in Bastrop county at 1675 Highway 71 East, Bastrop, TX, 78602. You can reach out to the office of Bio-Medical Applications Of Texas at (512) 332-0175. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Texas has the following ownership type - Profit. It was first certified by medicare in September, 2017. The medicare id for this facility is 672821 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Texas
Location	1675 Highway 71 East, Bastrop, Texas
No. of Dialysis Stations	13
Medicare ID	672821
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Texas from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1487026340
Organization Name	Fresenius Medical Care East Bastrop
Doing Business As	Bio-medical Applications Of Texas, Inc.
Address	1675 Highway 71 E Bastrop, Texas, 78602
Phone Number	(512) 332-0175

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	6
  Adult patient months included in Kt/V greater than or equal to 1.2	31
  Percentage of adult patients getting regular hemodialysis at the center
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Texas with elevated calcium levels.

Patients with hypercalcemia	6
Hypercalcemia patient months	31
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor	7
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	3
Patient months included in arterial venous fistula and catheter summaries	3
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer